Otonomy, Inc. Logo
Otonomy and AGTC Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
May 14, 2021 07:30 ET | Otonomy, Inc.
SAN DIEGO, May 14, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Presents HOPE-B Clinical Data Demonstrating Clinical Benefit in Hemophilia B Patients with Pre-existing Antibodies to AAV5 Vector
May 13, 2021 07:00 ET | uniQure Inc.
~ Data Show No Clinically Significant Correlation Between Pre-Existing NAbs and FIX Activity ~ ~ Further Supports Potential for AAV5 Gene Therapies to be Viable Treatments in Nearly All Patients -- ...
Freeline_Logo_Red_RGB.jpg
Freeline Presents Data Highlighting Platform Technology at the American Society of Gene and Cell Therapy Annual Meeting 2021
May 11, 2021 07:00 ET | Freeline Therapeutics
LONDON, May 11, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene...
Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting
May 10, 2021 10:00 ET | Vivet Therapeutics
Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting Compelling...
ShapeTX_Logo_BLUE.png
Shape Therapeutics Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 04, 2021 08:00 ET | Shape Therapeutics, Inc.
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced two abstracts...
Decibel-full color-CMYK.png
Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy 24th Annual Meeting
April 28, 2021 08:00 ET | Decibel Therapeutics, Inc.
BOSTON, April 28, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...
Otonomy, Inc. Logo
Otonomy and AGTC to Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
April 28, 2021 07:30 ET | Otonomy, Inc.
SAN DIEGO, April 28, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
April 28, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 28, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Sana_Logo_RGB-72_Blue.png
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
April 27, 2021 16:35 ET | Sana Biotechnology, Inc
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple cell types, including T cells and hepatocytes — SEATTLE, April 27, 2021 (GLOBE NEWSWIRE)...
Imanis Life Sciences logo
Imanis Life Sciences to Present IMMUNO-COV, a First-in-Class Neutralizing Antibody Test for COVID-19, at American Society of Gene and Cell Therapy Symposium
September 14, 2020 09:30 ET | Vyriad
High-throughput clinical assay detects, quantifies SARS-CoV-2-neutralizing antibodies Imanis Life Sciences is an affiliate of Vyriad Inc. ROCHESTER, Minn., Sept. 14, 2020 (GLOBE NEWSWIRE) --...